MBIO (STOCKS)
Mustang Bio, Inc.
$0.707900
-0.031800 (-4.30%)
Prev close: $0.739700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Manuel Litchman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.31M
- Employees
- 6
- P/E (TTM)
- -1.54
- P/B (TTM)
- 0.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-37.95 | $-8.16 | -29.7900 | -365.07% |
|
Sep 2024 (Q3)
|
$-2.00 | $-6.63 | +4.6300 | +69.83% |
|
Dec 2023 (Q4)
|
$-43.00 | $-67.83 | +24.8300 | +36.61% |
|
Sep 2023 (Q3)
|
$-70.00 | $-65.03 | -4.9750 | -7.65% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $514.00K |
| Operating Expenses | $3.24M |
| Operating Income/Loss | -$3.24M |
| Income/Loss From Continuing Operations After Tax | -$2.75M |
| Income/Loss From Continuing Operations Before Tax | -$2.72M |
| Net Income/Loss | -$2.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 17,513,918 |
| Diluted Average Shares | 17,513,918 |
| Assets | $16.58M |
| Current Assets | $16.58M |
| Noncurrent Assets | $0.00 |
| Liabilities | $7.99M |
| Current Liabilities | $7.84M |
| Accounts Payable | $3.34M |
| Other Current Liabilities | $4.50M |
| Noncurrent Liabilities | $150.00K |
| Equity | $8.60M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.60M |
| Liabilities And Equity | $16.58M |
| Net Cash Flow From Operating Activities | -$4.88M |
| Net Cash Flow From Operating Activities, Continuing | -$4.88M |
| Net Cash Flow From Investing Activities | $0.00 |
| Net Cash Flow From Financing Activities | $6.91M |
| Net Cash Flow | $2.03M |
| Net Cash Flow, Continuing | $2.03M |
| Comprehensive Income/Loss | -$2.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.72M |
| Other Comprehensive Income/Loss | $0.00 |